Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02097563 · ClinicalTrials.gov registry record · Phase 2
Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders
A Phase 2 study of Mood Disorders and Psychotic Disorders, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 133
- Enrollment target
- 3
- Study locations
NCT02097563: Completed Phase 2 study of Mood Disorders and Psychotic Disorders, sponsored by University of California, Los Angeles.
NCT02097563 is a Phase 2 study of Mood Disorders and Psychotic Disorders that has completed, run by University of California, Los Angeles. The registered enrollment target is 133 participants, below the 934-participant average among 39 other Mood Disorders trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02097563, a Phase 2 study of Mood Disorders and Psychotic Disorders, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 133 participants
- Enrollment target
- 3
- Study locations
Study Summary
The present study aims to : 1. compare different approaches (high intensity vs. low intensity) to training community providers (those who routinely treat young patients with bipolar disorder, psychosis, or sub-threshold high-risk conditions) on the implementation of family-focused treatment (FFT); 2. assess the cost of FFT training and implementation support; and 3. determine whether these different forms of clinician training are associated with different outcomes over 1 year among patients with early-onset mood and psychotic disorders.
Primary Outcome
This is a measure of how well the clinician administered family-focused treatment (FFT) based on ratings of audiotapes of family intervention sessions. These ratings are made every third session in both training conditions. This is an overall rating that can vary from 1 (nonadherent) to 7 (excellent adherence)
Conditions Studied
Interventions
- BEHAVIORAL High Intensity Training
- BEHAVIORAL Low Intensity Training
Study Locations (3)
California
- Didi Hirsch Mental Health Services - Culver City
- San Fernando Mental Health Center - Granada Hills
- Harbor/UCLA Outpatient Psychiatry Porgram - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2019-01-01 |
| Phase | Phase 2 |
What the finished NCT02097563 record still lists
NCT02097563 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 934-participant average among 39 other Mood Disorders trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Mood Disorders appearing as the primary indexed condition, and to 2 interventions - of which High Intensity Training is the first listed.
NCT02097563 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02097563 about?
NCT02097563 is a clinical study titled "Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders". The present study aims to : 1. compare different approaches (high intensity vs. low intensity) to training community providers (those who routinely treat young patients with bipolar disorder, psychosis, or sub-threshold high-risk conditions) on the implementation of family-focused treatment (FFT); ...
What is the current status of trial NCT02097563?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 133 participants. The study started on 2014-06-01. Estimated completion is 2019-01-01.
What conditions does trial NCT02097563 study?
This clinical trial studies the following conditions: Mood Disorders, Psychotic Disorders.
What interventions are being tested in trial NCT02097563?
The interventions under investigation include: High Intensity Training (BEHAVIORAL), Low Intensity Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02097563?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02097563 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mood Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02097563's enrollment target sits among peer trials
133 25th of 39 higher than 15 of 39 other Mood Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mood Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
RECRUITING · Phase 2
-
Individualized Functional Connectivity Targeting in aiTBS for Depression
ACTIVE NOT RECRUITING · Phase 2
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Clinical Validation of Samsung Smartwatch
RECRUITING
-
A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI